SBIN 746.75 -21.05 (-2.74%) WIPRO 242.85 -3.40 (-1.38%) ASIANPAINT 2,338.95 -16.10 (-0.68%) DMART 4,024.15 -15.15 (-0.38%) BPCL 274.40 -5.00 (-1.79%) SUNPHARMA 1,668.35 -41.05 (-2.40%) RELIANCE 1,166.20 -38.50 (-3.20%) ONGC 219.90 -6.10 (-2.70%) HCLTECH 1,375.30 -46.50 (-3.27%) LT 3,070.85 -188.35 (-5.78%) HDFCLIFE 666.35 -22.75 (-3.30%) NESTLEIND 2,247.70 -13.75 (-0.61%) ULTRACEMCO 11,192.65 -304.30 (-2.65%) AXISBANK 1,048.95 -40.55 (-3.72%) BRITANNIA 5,056.05 +31.20 (0.62%) ITC 406.05 -3.50 (-0.85%) BAJFINANCE 8,567.10 -153.75 (-1.76%) BHARTIARTL 1,687.85 -55.40 (-3.18%) NTPC 350.00 -0.45 (-0.13%) HDFC 2,729.95 -17.05 (-0.62%) POWERGRID 289.35 -4.45 (-1.51%) ICICIBANK 1,287.65 -47.30 (-3.54%) INFY 1,397.80 -54.50 (-3.75%) HDFCBANK 1,758.15 -58.85 (-3.24%) HINDUNILVR 2,250.15 +5.70 (0.25%) TCS 3,276.60 -22.85 (-0.69%) BAJAJFINSV 1,852.15 -60.00 (-3.14%) MARUTI 11,327.25 -154.30 (-1.34%) KOTAKBANK 2,039.20 -93.75 (-4.40%) TITAN 3,023.65 -52.50 (-1.71%)

Download Unicorn Signals App

By EquityPandit

Aurobindo Pharma has got USFDA approval for two generic drugs

June 22, 2015

On Monday, Aurobindo Pharma has announced the receipt of final approval from the US health regulator for manufacturing and marketing its generic versions of Parkinson’s disease treatment drug Entacapone tablets and anti-biotics Azithromycin in the American market.

According to a statement by the company, The approval by the US Food and Drug Administration (USFDA) to manufacture and market Entacapone Tablets is for strength of 200mg and product will be launched soon.

Read useful tips on Indian share market

Latest
IPO

Weekly
Outlook

Stock

Market
Prediction